Oxidative stress and DNA interactions are not involved in Enniatin- and Beauvericin-mediated apoptosis induction.

The fusariotoxins beauvericin (BEA) and the structurally related enniatins (ENN) are frequent contaminants of grain-based food and feed. They exert potent cytotoxic activities based on apoptosis induction. Since it is known, that reactive oxygen species (ROS) and DNA damage lead to apoptotic cell death, this study aimed to clarify whether oxidative stress and DNA interactions are involved in ENN- and BEA-induced cytotoxicity. Diverse cellular and molecular assays indicated that oxidative stress does not contribute to ENN- and BEA-induced cytotoxicity. In contrast, both fusariotoxins were shown to exert moderate antioxidative activities. Moreover, only at high concentrations (>100 microM) both mycotoxins were found to intercalate substantially into dsDNA and to inhibit the catalytic activity of topoisomerase I and II. Furthermore, the potent cytotoxic activity of ENN and BEA was shown to be widely independent of cellular mismatch- and nucleotide excision repair pathways. Also the ataxia-telangiectasia mutated (ATM) protein kinase, a well known DNA damage sensor, did not affect BEAs cytotoxic potential while in ENN-induced cytotoxicity ATM had a detectable but not a major modulating influence. Together, our data suggest that ROS and DNA damage are not key factors in ENN- and BEA-mediated cytotoxicity.

[1]  M. Broggini,et al.  Characterization of a protein recognizing minor groove binders-damaged DNA. , 1996, Nucleic acids research.

[2]  W. Berger,et al.  Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins. , 1997, Experimental cell research.

[3]  M. Center,et al.  Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. , 1988, Cancer research.

[4]  H. Bernstein,et al.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. , 2002, Mutation research.

[5]  Sajeev P. Cherian,et al.  Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. , 1994, Cancer research.

[6]  S. Pepeljnjak,et al.  Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B(1), beauvericin and ochratoxin A. , 2007, Basic & clinical pharmacology & toxicology.

[7]  S. Moukha,et al.  Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. , 2005, Toxicology.

[8]  H. Yamazaki,et al.  Activation and detoxication of aflatoxin B1. , 1998, Mutation research.

[9]  Raymond R Tice,et al.  Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. , 2007, Mutation research.

[10]  Alan P. Brown,et al.  Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat , 2002, Cancer Chemotherapy and Pharmacology.

[11]  A. Logrieco,et al.  The mycotoxins beauvericin and T-2 induce cell death and alteration to the ascorbate metabolism in tomato protoplasts , 2004 .

[12]  Ronald D Snyder,et al.  Assessment of atypical DNA intercalating agents in biological and in silico systems. , 2007, Mutation research.

[13]  Y. Tse‐Dinh Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases. , 2007, Infectious disorders drug targets.

[14]  G. Speit,et al.  The comet assay: a sensitive genotoxicity test for the detection of DNA damage. , 2005, Methods in molecular biology.

[15]  S. Kamitori,et al.  Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. , 1992, Journal of molecular biology.

[16]  W. Berger,et al.  Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  R. Hampson Selection for genome instability by DNA damage in human cells: unstable microsatellites and their consequences for tumourigenesis. , 1997, Radiation oncology investigations.

[18]  F. Bushman,et al.  Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A. , 1999, Molecular pharmacology.

[19]  Antonio Costanzo,et al.  The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.

[20]  E. Larson,et al.  Human Mismatch Repair and G·T Mismatch Binding by hMutSαin Vitro Is Inhibited by Adriamycin, Actinomycin D, and Nogalamycin* , 2001, The Journal of Biological Chemistry.

[21]  Marika Jestoi,et al.  Emerging Fusarium -Mycotoxins Fusaproliferin, Beauvericin, Enniatins, And Moniliformin—A Review , 2008, Critical reviews in food science and nutrition.

[22]  Y. Higuchi Glutathione depletion‐induced chromosomal DNA fragmentation associated with apoptosis and necrosis , 2004, Journal of cellular and molecular medicine.

[23]  Morten O. Christensen,et al.  Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity. , 2005, Chemical research in toxicology.

[24]  A. Boulares,et al.  Roles of oxidative stress and glutathione depletion in JP-8 jet fuel-induced apoptosis in rat lung epithelial cells. , 2002, Toxicology and applied pharmacology.

[25]  T. Paraidathathu,et al.  The use of fluorescent probes to assess oxidative processes in isolated-perfused rat heart tissue. , 1992, Free radical research communications.

[26]  H. Rubinstein,et al.  Immunobiological Effects of Fumonisin B1 in Experimental Subchronic Mycotoxicoses in Rats , 2002, Clinical and Vaccine Immunology.

[27]  K. Savolainen,et al.  Oxidative Stress Induced by Fumonisin B1 in Continuous Human and Rodent Neural Cell Cultures , 2004, Free radical research.

[28]  M. Ueda,et al.  [Xeroderma pigmentosum]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[29]  B. Fanburg,et al.  Regulation of cellular glutathione. , 1989, The American journal of physiology.

[30]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[31]  W. Berger,et al.  Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin. , 2009, Molecular nutrition & food research.

[32]  C. Chou,et al.  Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. , 2004, Cancer letters.

[33]  I. Pastan,et al.  Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. , 1986, The Journal of biological chemistry.

[34]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[35]  B. Jollès,et al.  Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs. , 1996, Chemico-biological interactions.

[36]  H. von Döhren,et al.  Nonribosomal biosynthesis of peptide antibiotics. , 1990, European journal of biochemistry.

[37]  H. Wang,et al.  Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228. , 2002, The Journal of pharmacology and experimental therapeutics.

[38]  W. Berger,et al.  Mechanisms underlying the anticancer activities of the angucycline landomycin E. , 2007, Biochemical pharmacology.

[39]  R. Lemmens‐Gruber,et al.  Investigation of the electrophysiological properties of enniatins. , 2004, Archives of biochemistry and biophysics.

[40]  L. Prakash,et al.  The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. , 1994, Cancer research.

[41]  P. Ferranti,et al.  Observation of non-covalent interactions between beauvericin and oligonucleotides using electrospray ionization mass spectrometry. , 1997, Rapid communications in mass spectrometry : RCM.

[42]  J. Sarkaria,et al.  ATM as a target for novel radiosensitizers. , 2001, Seminars in radiation oncology.

[43]  I. Molnár,et al.  Cytotoxic and Antihaptotactic beauvericin analogues from precursor-directed biosynthesis with the insect pathogen Beauveria bassiana ATCC 7159. , 2007, Journal of natural products.

[44]  J. Cherton,et al.  Conjugation reactions of cyclodepsipeptide to glutathionyl adducts by direct 'in-beam' synthesis under negative-ion fast-atom bombardment conditions. , 1994, Rapid communications in mass spectrometry : RCM.

[45]  L. Wiesmüller,et al.  p53 in recombination and repair , 2006, Cell Death and Differentiation.

[46]  Hen-I Lin,et al.  Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. , 2005, Cancer letters.

[47]  K. Tanaka,et al.  Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids. , 1995, Carcinogenesis.

[48]  V. Cardile,et al.  DNA damage in human fibroblasts exposed to fumonisin B(1). , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[49]  Petra Heffeter,et al.  Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24). , 2006, Biochemical pharmacology.

[50]  W. Berger,et al.  Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells. , 2007, Chemical research in toxicology.

[51]  L. Macchia,et al.  Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. , 2004, Pharmacological research.

[52]  J. D. Young,et al.  Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes. , 1991, Experimental cell research.

[53]  K. Kohn,et al.  Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. , 1990, Molecular pharmacology.

[54]  M. A. Dombrink-Kurtzman Fumonisin and Beauvericin Induce Apoptosis in Turkey Peripheral Blood Lymphocytes , 2004, Mycopathologia.

[55]  L. Macchia,et al.  Beauvericin cytotoxicity to the invertebrate cell line SF-9. , 2003, Journal of applied genetics.

[56]  B. Rigas,et al.  Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer , 2008, British Journal of Cancer.

[57]  Jixun Zhan,et al.  Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum. , 2007, Journal of natural products.

[58]  J. Cherton,et al.  Characterization of cyclodepsipeptide-glutathionyl conjugates by negative-ion fast-atom bombardment linked-scan mass spectrometry. , 1994, Rapid communications in mass spectrometry : RCM.

[59]  J. Perez-polo,et al.  DNA Damage in Astrocytes Exposed to Fumonisin B1 , 2002, Neurochemical Research.